2019年度発表論文等一覧

原著論文－英文

1. Matsuyama S, Nao N, Shirato K, Kawase M, Saito S, Takayama I, Nagata N, Sekizuka T, Katoh H, Kato F, Sakata M, Tahara M, Kutsuna S, Ohmagari N, Kuroda M, Suzuki T, Kageyama T, Takeda M.
   Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells.
   Proceedings of the National Academy of Sciences of the United States of America, 117(13), Mar, 2020.
2. Akasaka H, Yamamoto K, Rakugi H, Nagasawa M, Nakamaru R, Ichijo T, Takeda Y, Kurihara I, Katabami T, Tsuiki M, Wada N, Ogawa Y, Kawashima J, Sone M, Kamemura K, Yoshimoto T, Matsuda Y, Fujita M, Kobayashi H, Watanabe M, Tamura K, Okamura S, Miyauchi S, Izawa S, Chiba Y, Tanabe A, Naruse M. Japan Primary Aldosteronism Study Group, Sex Difference in the Association Between Subtype Distribution and Age at Diagnosis in Patients With Primary Aldosteronism. Hypertension, 74(2), Aug, 2019.
3. Akazawa T, Kusama Y, Fukuda H, Hayakawa K, Kutsuna S, Moriyama Y, Ohashi H, Tamura S, Yamamoto K, Hara R, Shigeno A, Ota M, Ishikane M, Tokita S, Terakado H, Ohmagari N.
   Eight-Year Experience of Antimicrobial Stewardship Program and the Trend of Carbapenem Use at a Tertiary Acute-Care Hospital in Japan-The Impact of Postprescription Review and Feedback.
   Open Forum Infect Disease, 6(10), Sep 2019.
4. Nakatochi M, Kanai M, Nakayama A, Hishida A, Kawamura Y, Ichihara S, Akiyama M, Ikezaki H, Furusyo N, Shimizu S, Yamamoto K, Hirata M, Okada R, Kawai S, Kawaguchi M, Nishida Y, Shimanoe C, Ibusuki R, Takezaki T, Nakajima M, Takao M, Ozaki E, Matsui D, Nishiyama T, Suzuki S, Takashima N, Kita Y, Endoh K, Kuriki K, Uemura H, Arisawa K, Oze I, Matsuo K, Nakamura Y, Mikami H, Tamura T, Nakashima H, Nakamura T, Kato N, Matsuda K, Murakami Y, Matsubara T, Naito M, Kubo M, Kamatani Y, Shinomiya N, Yokota M, Wakai K, Okada Y, Matsuo H.
   Genome-wide meta-analysis identifies multiple novel loci associated with serum uric acid levels in Japanese individuals.
   Communication Biology, 2, Apr, 2019.
5. Kubota H, Suzuki Y, Okuno R, Uchitani Y, Ariyoshi T, Takemura N, Mihara F, Mezaki K, Ohmagari N, Matsui M, Suzuki S, Sekizuka T, Kuroda M, Yokoyama K, Sadamasu K.
   IMP-68, a Novel IMP-Type Metallo-β-Lactamase in Imipenem-Susceptible Klebsiella pneumoniae.
   mSphere, 4(5), Oct, 2019.
6. Yamamoto K, Ujiie M, Noguchi A, Kato Y, Fujiya Y, Mawatari M, Kutsuna S, Takeshita N, Hayakawa K, Kanagawa S, Inoue S, Morikawa S, Ohmagari N.
   Rabies post-exposure prophylactic vaccination for returning travelers to Japan.
   Journal of Infection and Chemotherapy (JIC), 25(12), Dec, 2019.
7. Ngo CQ, Manabe T, Vu GV, Chu HT, Vu TTT, Tran TT, Doan LTP, Takasaki J, Kudo K.
   Difficulties in tuberculosis infection control in a general hospital of Vietnam: a knowledge, attitude, and practice survey and screening for latent tuberculosis infection among health professionals.
   BMC Infectious Diseases, 19(1), Nov, 2019.
8. Tamehiro N, Nishida K, Sugita Y, Hayakawa K, Oda H, Nitta T, Nakano M, Nishioka A, Yanobu-Takanashi R, Goto M, Okamura T, Adachi R, Kondo K, Morita A, Suzuki H.
   Ras homolog gene family H (RhoH) deficiency induces psoriasis-like chronic dermatitis by promoting TH17 cell polarization.
   Journal of Allergy and Clinical Immunology, 143(5), May, 2019.
9. Uda K, Kinoshita N, Morisaki N, Kasai M, Horikoshi Y, Miyairi I.
   Targets for Optimizing Oral Antibiotic Prescriptions for Pediatric Outpatients in Japan.
   Japanese Journal of Infectious Diseases (JJID), 72(3), May, 2019.
10. Kusama Y, Ishikane M, Tanaka C, Kimura Y, Yumura E, Hayakawa K, Muraki Y, Yamasaki D, Tanabe M, Ohmagari N.
    Regional Variation of Antimicrobial Use in Japan from 2013-2016, as Estimated by the Sales Data.
    Japanese Journal of Infectious Diseases (JJID), 72(5), Sep, 2019.
11. Kimura Y, Fukuda H, Hayakawa K, Ide S, Ota M, Saito S, Ishikane M, Kusama Y, Matsunaga N, Ohmagari N.
    Longitudinal trends of and factors associated with inappropriate antibiotic prescribing for non-bacterial acute respiratory tract infection in Japan: A retrospective claims database study, 2012-2017.
    PLoS One, 14(10), Oct, 2019.
12. Niikura R, Nagata N, Yamada A, Honda T, Hasatani K, Ishii N, Shiratori Y, Doyama H, Nishida T, Sumiyoshi T, Fujita T, Kiyotoki S, Yada T, Yamamoto K, Shinozaki T, Takata M, Mikami T, Mabe K, Hara K, Fujishiro M, Koike K.
    Efficacy and Safety of Early vs Elective Colonoscopy for Acute Lower Gastrointestinal Bleeding.
    Gastroenterology, 158(1), Jan, 2020.
13. Moriyama Y, Ishikane M, Hayakawa K, Yamamoto K, Akazawa T, Sugiki Y, Ohmagari N.
    Comparison of knowledge to antimicrobial stewardship institution policies targeting Staphylococcus aureus bacteremia and candidemia between medical doctors and pharmacists in an academic teaching hospital in Japan.
    Journal of Infection and Chemotherapy (JIC), 25(5), May, 2019.
14. Akiyama Y, Maeda D, Katoh H, Morikawa T, Niimi A, Nomiya A, Sato Y, Kawai T, Goto A, Fujimura T, Fukuhara H, Nakagawa T, Igawa Y, Ishikawa S, Fukayama M, Kume H, Homma Y.
    Molecular Taxonomy of Interstitial Cystitis/Bladder Pain Syndrome Based on Whole Transcriptome Profiling by Next-Generation RNA Sequencing of Bladder Mucosal Biopsies.
    Journal of Urology, 202(2), Aug, 2019.
15. Ishikane M, Arima Y, Itoda I, Yamagishi T, Takahashi T, Matsui T, Sunagawa T, Ohnishi M, Oishi K.
    Case-control study of risk factors for incident syphilis infection among men who have sex with men in Tokyo, Japan.
    Western Pacific Surveillance and Response Journal (WPSAR), 10(4), Dec, 2019.
16. Otsuka-Ono H, Hori N, Ohta H, Uemura Y, Kamibeppu K.
    A childhood immunization education program for parents delivered during late pregnancy and one-month postpartum: a randomized controlled trial.
    BMC Health Services Research, 19(1), Nov, 2019.
17. Inagaki A, Moriyama Y, Morioka S, Wakimoto Y, Shida Y, Ohmagari N.
    A case of Klebsiella pneumoniae spondylitis and bacteremia potentially due to inflammation around a fecalith.
    Journal of Infection and Chemotherapy (JIC), 25(6), Jun, 2019.
18. Takaya S, Kato Y, Katanami Y, Yamamoto K, Kutsuna S, Takeshita N, Hayakawa K, Kanagawa S, Komaki-Yasuda K, Kano S, Ohmagari N.
    Imported Malaria at a Referral Hospital in Tokyo from 2005 to 2016: Clinical Experience and Challenges in a Non-Endemic Setting.
    American Journal of Tropical Medicine and Hygiene, 100(4), Apr, 2019.
19. Sherchan JB, Tada T, Shrestha S, Uchida H, Hishinuma T, Morioka S, Shahi RK, Bhandari S, Twi RT, Kirikae T, Sherchand JB.
    Emergence of clinical isolates of highly carbapenem-resistant Klebsiella pneumoniae co-harboring bla (NDM-5) and bla (OXA-181 or -232) in Nepal.
    International Journal of Infectious Diseases (IJID), 92, Mar, 2020.
20. Manabe T, Takasaki J, Kudo K.
    Seasonality of newly notified pulmonary tuberculosis in Japan, 2007-2015.
    BMC Infectious Diseases, 19(1), Jun, 2019
21. Ishii S, Muraki Y, Kusama Y, Yagi T, Goto R, Ebisui A, Kawabe A, Inose R, Ohmagari N.
    The Trend for Antibiotic Use for Clostridioides (Clostridium) difficile Infection in Japan.
    Biological and Pharmaceutical Bulletin, 43(4), 2020.
22. Kusama Y, Ishikane M, Tanaka C, Tsuzuki S, Muraki Y, Ohmagari N.
    What is the impact of the change in DDD of amoxicillin and amoxicillin combined with β-lactamase inhibitors on nationwide surveillance of antimicrobial use?.
    Journal of Antimicrobial Chemotherapy, 74(10), Oct, 2019.
23. Ujiie M.
    Rubella Resurgence in Japan 2018-2019.
    J Travel Med, 26(6), Sep, 2019.
24. Ishikane M, Kusama Y, Tanaka C, Hayakawa K, Kuwahara T, Ohmagari N.
    Epidemiology of antimicrobial use among nursing homes in Japan, 2016: A pilot study.
    Japanese Journal of Infectious Diseases (JJID), Jan, 2020.
25. Hayakawa K, Nakano R, Hase R, Shimatani M, Kato H, Hasumi J, Doi A, Sekiya N, Nei T, Okinaka K, Kasahara K, Kurai H, Nagashima M, Miyoshi-Akiyama T, Kakuta R, Yano H, Ohmagari N.
    Comparison between IMP carbapenemase-producing Enterobacteriaceae and non-carbapenemase-producing Enterobacteriaceae: a multicentre prospective study of the clinical and molecular epidemiology of carbapenem-resistant Enterobacteriacea.
    Journal of Antimicrobial Chemother, 75(3), Mar, 2020.
26. Tachino J, Yamamoto K, Shimizu K, Shintani A, Kimura A, Ogura H, Shimazu T.
    Quick risk assessment profile (qRAP) is a prediction model for post-traumatic venous thromboembolism.
    Injury, 50(9), Sep, 2019.
27. Tsuzuki S, Fujitsuka N, Horiuchi K, Ijichi S, Gu Y, Fujitomo Y, Takahashi R, Ohmagari N.
    Factors associated with sufficient knowledge of antibiotics and antimicrobial resistance in the Japanese general population.
    Scientific Reports, 10(1), Feb, 2020.
28. Tsuzuki S, Baguelin M, Pebody R, van Leeuwen E.
    Modelling the optimal target age group for seasonal influenza vaccination in Japan.
    Vaccine, 38(4), Jan, 2020.
29. Saiki A, Otsuki M, Mukai K, Hayashi R, Shimomura I, Kurihara I, Ichijo T, Takeda Y, Katabami T, Tsuiki M, Wada N, Ogawa Y, Kawashima J, Sone M, Inagaki N, Yoshimoto T, Okamoto R, Takahashi K, Kobayashi H, Tamura K, Kamemura K, Yamamoto K, Izawa S, Kakutani M, Yamada M, Tanabe A, Naruse M.
    Basal Plasma Aldosterone Concentration Predicts Therapeutic Outcomes in Primary Aldosteronism.
    Journal of the Endocrine Society, 4(4), Feb, 2020.
30. Gu Y, Fujitomo Y, Soeda H, Nakahama C, Hasegawa N, Maesaki S, Maeda M, Matsumoto T, Miyairi I, Ohmagari N.
    A nationwide questionnaire survey of clinic doctors on antimicrobial stewardship in Japan.
    Journal of Infection and Chemotherapy (JIC), 26(2), Feb, 2020.
31. Matsui T, Kinoshita N, Maeki T, Kutsuna S, Nakamura K, Nakamoto T, Ishikane M, Tajima S, Kato F, Taniguchi S, Lim CK, Saijo M, Ohmagari N.
    Dengue Virus Type 2 Infection in a Traveler Returning from Saudi Arabia to Japan.
    Japanese Journal of Infectious Diseases (JJID). 2019, Sep, 72(5).
32. Matsui T, Nakamoto T, Hayakawa K, Yamamoto K, Nakamura K, Kutsuna S, Nagashima M, Toriniwa H, Komiya T, Ohmagari N.
    Case Report: Two Cases of Acute Q Fever from the Same Family Who Returned from Malawi to Japan.
    American Journal of Tropical Medicine and Hygiene, 101(6), Dec, 2019.
33. Mashima I, Miyoshi-Akiyama T, Tomida J, Kutsuna R, Washio J, Takahashi N, Nakazawa F, Sato T, Kawamura Y.
    Draft Genome Sequences of Two Veillonella tobetsuensis Clinical Isolates from Intraoperative Bronchial Fluids of Elderly Patients with Pulmonary Carcinoma.
    Microbiology Resource Announcements, 8(38), Sep, 2019.
34. Kusama Y, Muraki Y, Mochizuki T, Kurai H, Gu Y, Ohmagari N.
    Relationship between drug formulary and frequently used cephalosporins, macrolides and quinolones in Japanese hospitals.
    Journal of Infection and Chemotherapy (JIC), 26(2), Feb, 2020.
35. Morioka S, Tajima T, Sugiki Y, Hayakawa K, Ohmagari N.
    Adherence to personal protective equipment use among nurses in Japanese tertiary care hospitals: what determines variability?.
    Journal of Hospital Infection, 104(3), Mar, 2020.
36. Morioka S, Hashikura K, Nishio H, Ohmagari N.
    Anterior Tibial Artery Hemorrhaging Mimicking Necrotizing Fasciitis.
    Internal Medicine Journal, 58(20), Oct, 2019.
37. Tamura S, Hayakawa K, Miyoshi-Akiyama T, Nakanishi M, Yano T, Shimoya K, Sugiki Y, Mezaki K, Ohmagari N.
    Isolation of OXA-181 Carbapenemase-Producing Escherichia coli and OXA-232 Carbapenemase-Producing Klebsiella pneumoniae from a Pregnant Woman Returning to Japan from India.
    Japanese Journal of Infectious Diseases (JJID), 72(4), Jul, 2019.
38. Kakuwa T, Ariga A, Takasaki J, Kato M, Igari T, Shida Y, Okafuji T, Nakamura S, Miyazaki Y, Katano H, Iikura M, Izumi S, Sugiyama H.
    Mucor pulmonary embolism in a patient with myelodysplastic syndrome.
    Respiratory Medicine Case Reports, 30, Mar, 2020.
39. Ujihara T, Yamamoto K, Kitaura T, Katanami Y, Kutsuna S, Takeshita N, Hayakawa K, Ohmagari N.
    Calcium Pyrophosphate Deposition Disease Involving a Lumbar Facet Joint Following Urinary Tract Infection.
    Internal Medicine Journal, 58(12), Jun, 2019.
40. Suzuki T, Takaya S, Kunimatsu J, Kutsuna S, Hayakawa K, Shibata H, Yasumi T, Ohmagari N.
    GATA2 mutation underlies hemophagocytic lymphohistiocytosis in an adult with primary cytomegalovirus infection.
    Journal of Infection and Chemotherapy (JIC), 26(2), Feb, 2020.
41. Diaz-Menendez M, Esteban ET, Ujiie M, Calleri G, Rothe C, Malvy D, Nicastri E, Bissinger AL, Grandadam M, Alpern JD, Gobbi F, Schlagenhauf P, Duvignaud A, Javelle E, Nakamoto T, Antinori S, Hamer DH.
    Travel-associated chikungunya acquired in Myanmar in 2019.
    Euro Surveillance, 25(1), Jan, 2020.
42. Tanabe S, Kutsuna S, Tsuboi M, Takeshita N, Hayakawa K, Ohmagari N.
    Meningoencephalitis Caused by a Campylobacter fetus in a Patient with Chronic Alcoholism.
    Internal Medicine Journal, 58(15), Aug, 2019.
43. Ujiie M, Terada M, Kobayakawa M, Ohmagari N.
    Clinical trial with unlicensed yellow fever vaccine in Japan.
    Journal of Travel Medicine, 26(6), Sep, 2019.
44. Higashino T, Morimoto K, Nakaoka H, Toyoda Y, Kawamura Y, Shimizu S, Nakamura T, Hosomichi K, Nakayama A, Ooyama K, Ooyama H, Shimizu T, Ueno M, Ito T, Tamura T, Naito M, Nakashima H, Kawaguchi M, Takao M, Kawai Y, Osada N, Ichida K, Yamamoto K, Suzuki H, Shinomiya N, Inoue I, Takada T, Matsuo H.
    Dysfunctional missense variant of OAT10/SLC22A13 decreases gout risk and serum uric acid levels.
    Annals of the Rheumatic Diseases (ARD), 79(1), Jan, 2020.
45. Takaya S, Kutsuna S, Kato Y, Ohmagari N.
    The Authors' Reply to "Both Macro and Micro Filarial Treatment May Be Necessary to Treat Hydrocele Due to a Wuchereria bancrofti Infection.
    Internal Medicine, 58(16), Aug, 2019.
46. Tanabe S, Kutsuna S, Tsuboi M, Takeshita N, Hayakawa K, Ohmagari N.
    Reply to "Initial Narrow- or Broad-spectrum Treatment for Meningoencephalitis".
    Internal Medicine, 59(3), Feb, 2020.
47. Yamamoto K, Yanagawa Y, Oka S, Watanabe K.
    Two cases of endoscopically diagnosed amebic colitis treated with paromomycin monotherapyPLoS Neglected Tropical Diseases, 14(3), Mar, 2020.
48. Kizaki M, Takahashi N, Iriyama N, Okamoto S, Ono T, Usui N, Inokuchi K, Nakaseko C, Kurokawa M, Sumi M, Nakamura F, Kawaguchi T, Suzuki R, Yamamoto K, Ohnishi K, Matsumura I, Naoe T; New TARGET investigators.
    Efficacy and safety of tyrosine kinase inhibitors for newly diagnosed chronic-phase chronic myeloid leukemia over a 5-year period: results from the Japanese registry obtained by the New TARGET system.
    International Journal of Hematology (IJH), 109(4), Apr, 2019.
49. Uda K, Okubo Y, Kinoshita N, Morisaki N, Kasai M, Horikoshi Y, Miyairi I.
    Nationwide survey of indications for oral antimicrobial prescription for pediatric patients from 2013 to 2016 in Japan.
    Journal of Infection and Chemotherapy (JIC), 25(10), Oct, 2019.
50. Mori A, Hatano T, Inoshita T, Shiba-Fukushima K, Koinuma T, Meng H, Kubo SI, Spratt S, Cui C, Yamashita C, Miki Y, Yamamoto K, Hirabayashi T, Murakami M, Takahashi Y, Shindou H, Nonaka T, Hasegawa M, Okuzumi A, Imai Y, Hattori N.
    Parkinson's disease-associated iPLA2-VIA/PLA2G6 regulates neuronal functions and α-synuclein stability through membrane remodeling.
    Proceedings of the National Academy of Sciences of the United States of America, 116(41), Oct, 2019.
51. Jinnin M, Ohta A, Ishihara S, Amano H, Atsumi T, Fujimoto M, Kanda T, Kawaguchi Y, Kawakami A, Mimori A, Mimori T, Mimura T, Muro Y, Sano H, Shimizu J, Takeuchi T, Tanaka Y, Yamamoto K, Sumida T, Kohsaka H; Research Team for Autoimmune Diseases, The Research Program for Intractable Disease of the Ministry of Health, Labor and Welfare.
    First external validation of sensitivity and specificity of the European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria for idiopathic inflammatory myopathies with a Japanese cohort.
    Annals of the Rheumatic Diseases (ARD), 79(3), Mar, 2020.
52. Harada S, Aoki K, Yamamoto S, Ishii Y, Sekiya N, Kurai H, Furukawa K, Doi A, Tochitani K, Kubo K, Yamaguchi Y, Narita M, Kamiyama S, Suzuki J, Fukuchi T, Gu Y, Okinaka K, Shiiki S, Hayakawa K, Tachikawa N, Kasahara K, Nakamura T, Yokota K, Komatsu M, Takamiya M, Tateda K, Doi Y.
    Clinical and Molecular Characteristics of Klebsiella pneumoniae Isolates Causing Bloodstream Infections in Japan: Occurrence of Hypervirulent Infections in Health Care.
    Journal of Clinical Microbiology, 57(11), Oct, 2019.
53. Yanagihara K, Matsumoto T, Aoki N, Sato J, Wakamura T, Kiyota H, Tateda K, Hanaki H, Ohsaki Y, Fujiuchi S, Takahashi M, Akiba Y, Masunaga S, Takeuchi K, Takeda H, Miki M, Kumagai T, Takahashi H, Utagawa M, Nishiya H, Kawakami S, Ishigaki S, Kobayasi N, Takasaki J, Mezaki K, Iwata S, Katouno Y, Inose R, Niki Y, Kawana A, Fujikura Y, Kudo M, Hirano T, Yamamoto M, Miyazawa N, Tsukada H, Aso S, Yamamoto Y, Iinuma Y, Mikamo H, Yamagishi Y, Nakamura A, Ohashi M, Kawabata A, Sugaki Y, Seki M, Hamaguchi S, Toyokawa M, Kakeya H, Fujikawa Y, Mitsuno N, Ukimura A, Miyara T, Hayasi M, Mikasa K, Kasahara K, Koizumi A, Korohasi N, Matumoto T, Yosimura Y, Katanami Y, Takesue Y, Wada Y, Sugimoto K, Yamamoto T, Kuwabara M, Doi M, Simizu S, Tokuyasu H, Hino S, Negayama K, Mukae H, Kawanami T, Yatera K, Fujita M, Kadota J, Hiramatsu K, Aoki Y, Magarifuchi H, Oho M, Morinaga Y, Suga M, Muranaka H, Fujita J, Higa F, Tateyama M.
    Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for clinical microbiology in 2014: General view of the pathogens' antibacterial susceptibility.
    Journal of Infection and Chemotherapy (JIC), 25(9), Sep, 2019.
54. Moriyama Y, Ishikane M, Mezaki K, Ohmagari N.
    Comparison of penicillins (penicillin G and ampicillin) and cefazolin as a definitive therapy against penicillin-susceptible Staphylococcus aureus (PSSA) bacteremia in Japan: a retrospective cohort study.
    Journal of Infection and Chemotherapy (JIC), 26(4), Dec, 2019.
55. Tsuzuki S, Matsunaga N, Yahara K, Gu Y, Hayakawa K, Hirabayashi A, Kajihara T, Sugai M, Shibayama K, Ohmagari N.
    National trend of blood-stream infection attributable deaths caused by Staphylococcus aureus and Escherichia coli in Japan.
    Journal of Infection and Chemotherapy (JIC), 26(4), Dec, 2019.
56. Kinoshita N, Komura M, Tsuzuki S, Shoji K, Miyairi I.
    The effect of preauthorization and prospective audit and feedback system on oral antimicrobial prescription for outpatients at a children's hospital in Japan.
    Journal of Infection and Chemotherapy (JIC), 26(6), Feb, 2020.
57. Takaya S, Hayakawa K, Matsunaga N, Moriyama Y, Katanami Y, Tajima T, Tanaka C, Kimura Y, Saito S, Kusama Y, Morioka S, Fujitomo Y, Ohmagari N.
    Surveillance systems for healthcare-associated infection in high and upper-middle income countries: A scoping review.
    Journal of Infection and Chemotherapy (JIC), 26(5), Feb, 2020.
58. Maeda M, Muraki Y, Anno Y, Sawa A, Kusama Y, Ishikane M, Ohmagari N, Ohge H.
    Development of the predicted and standardized carbapenem usage metric: Analysis of the Japanese Diagnosis Procedure Combination payment system data.
    Journal of Infection and Chemotherapy (JIC), 26(6), Mar, 2020.
59. Tsuzuki S, Fujitsuka N, Horiuchi K, Ijichi S, Gu Y, Fujitomo Y, Takahashi R, Ohmagari N.
    Factors associated with sufficient knowledge of antibiotics and antimicrobial resistance in the Japanese general population.
    Scientific Reports, 10(1), Feb, 2020.
60. Tsuzuki S, Baguelin M, Pebody R, van Leeuwen E.
    Modelling the optimal target age group for seasonal influenza vaccination in Japan.
    Vaccine, 38(4), Jan, 2020.
61. Tsuzuki S, Kimura Y, Ishikane M, Kusama Y, Ohmagari N.
    Cost of inappropriate antimicrobial use for upper respiratory infection in Japan.
    BMC Health Services Research, 20(1), Feb, 2020.
62. Tsuzuki S, Matsunaga N, Yahara K, Gu Y, Hayakawa K, Hirabayashi A, Kajihara T, Sugai M, Shibayama K, Ohmagari N.
    National trend of blood-stream infection attributable deaths caused by Staphylococcus aureus and Escherichia coli in Japan.
    Journal of Infection and Chemotherapy (JIC), 26(4), Dec, 2019.
63. Kanamori K, Shoji K, Kinoshita N, Ishiguro A, Miyairi I.
    Complications of Herpes Zoster in Children.
    Pediatrics International, 61(12), Dec, 2019.
64. Tao C, Kinoshita N, Shoji K, Motooka D, Nakamura S, Eura R, Ueoka K, Kubota M, Ishiguro A, Miyairi I.
    Urinary tract infection due to anaerobic bacteria in a two-month-old infant.
    Journal of Infection and Chemotherapy (JIC), 25(5), May, 2019.
65. Yamamoto K.
    Oral Manifestation Like Forchheimer Spots of Dengue Fever.
    American Journal of Tropical Medicine and Hygiene, 101(4), Oct, 2019.
66. Akashi H, Ishizuka A, Lee S, Irie M, Oketani H, Akashi R.
    The role of the G20 economies in global health.
    Global Health & Medicine, 1(1), Nov, 2019.

原著論文－和文

1. 中本 貴人.
   渡航先で診断された腸管アメーバ症の現状.
   Clinical Parasitology(1341-5190), 30巻1号, 37-39, 2019, 12月.
2. 山元佳 (Yamamoto K.)
   Rabies post-exposure prophylactic vaccination for returning travelers to Japan(和訳中)(英語).
   Journal of Infection and Chemotherapy(1341-321X), 25巻11-12号, 931-935, 2019, 12月.
3. 具 芳明.
   全国の診療所医師を対象とした抗菌薬適正使用に関するアンケート調査.
   感染症学雑誌(0387-5911), 93巻3号, 289-297, 2019, 5月.
4. 日馬 由貴 (Kusama Y).
   売上高データにより評価した日本における2013～2016年の抗菌剤使用の地域差(Regional Variation of Antimicrobial Use in Japan from 2013-2016, as Estimated by the Sales Data)(英語).
   Japanese Journal of Infectious Diseases(1344-6304), 72巻5号, 326-329, 2019, 9月.
5. 氏原哲郎 (Ujihara T).
   尿路感染症後の腰椎椎間関節に浸潤するピロリン酸カルシウム結晶沈着症(Calcium Pyrophosphate Deposition Disease Involving a Lumbar Facet Joint Following Urinary Tract Infection)(英語).
   Internal Medicine(0918-2918), 58巻12号, 1787-1789, 2019, 6月.
6. 日馬 由貴.
   病院の検査室における血液培養検査対応の現状.
   日本臨床微生物学会雑誌(2434-866X), 29巻2号, 88-91, 2019, 3月.
7. 具 芳明.
   全国の診療所医師を対象とした抗菌薬適正使用に関するアンケート調査.
   日本化学療法学会雑誌(1340-7007), 67巻3号, 295-307, 2019, 5月.
8. 日馬 由貴.
   適切な感染症治療を推進するための保険診療審査情報の開示　社会保険診療報酬支払基金による審査情報提供事例の有効活用.
   感染症学雑誌(0387-5911), 93巻1号, 25-29, 2019, 1月.

口頭・ポスター発表－国際学会・研究会

1. Tsuzuki S.
   The Characteristics of Influenza-Like Illness Management in Japan.
   IDWEEK 2019, Washington D.C., US, October 2019.
2. Tsuzuki S, Kimura Y, Ishikane M, Kusama Y, Ohmagari N.
   Cost of Antimicrobial Use for Upper Respiratory Infection in Japan.
   IDWEEK 2019, Washington D.C., US, October 2019.
3. Yamamoto K.
   Which Type of Varicella-Zoster Virus Infection is at High Risk for Airborne Transmissions?.
   29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Amsterdam, Netherlands, April, 2019.
4. Yamamoto K.
   Catch-up Measles, Mumps, Rubella, and Varicella Immunization on Pretravel Consultation in Japan.
   CISTM, Washington D.C., US, June, 2019.
5. Gu Y, Fujitomo Y, Takahashi R, Ohmagari N.
   Effect of Media Strategy for Public Awareness-raising Activities on Antimicrobial Resistance in Japan.
   The 5th International Conference on Prevention and Infection Control. Geneva, Switzerland, September, 2019.
6. Gu Y.
   Country deep dive on Japan: High to middle income AMR strategies.
   Antimicrobial Resistance Summit.  Singapore, Singapore, October, 2019.
7. Nomoto H, Ishikane M, Ohmagari N.
   Clinical characteristics of adult rubella observed during an outbreak in Japan in 2018.
   29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Amsterdam, Netherlands, April, 2019.
8. Kusama Y, Ishikane M, Tanaka C, Kimura Y, Yamasaki D, Tanabe M, Murai Y, Ohmagari N.
   Aminoglycoside injections are the most frequently prescribed to children in outpatient settings: nation-wide population-based study in Japan in 2016.
   29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Amsterdam, Netherlands, April, 2019.
9. Kusama Y, Ishikane M, Fukuda M, Yumura E, Tanaka C, Kimura Y, Hayakawa K, Muraki Y, Yamasaki D, Tanabe M, Ohmagari N.
   Decreasing of national antibiotic consumption and economic impact during 2013-2017 in Japan.
   29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Amsterdam, Netherlands, April, 2019.
10. Ishikane M, Tanaka C, Ono S, Kusama Y, Tsuzuki S, Muraki Y, Yamasaki D, Tanabe M, Ohmagari N.
    First National Survey of Antibiotic Use Prescribed by All Dentists in Japan from 2015 to 2017 using the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
    IDWEEK 2019, Washington D.C., US, October 2019.
11. Kusama Y, Ishikane M, Kihara T, Ohmagari N.
    Cephalosporins and Quinolones Account for Ninety-five Percent of Oral Antibiotic Treatment for Uncomplicated Cystitis in Japan.
    IDWEEK 2019, Washington D.C., US, October 2019.
12. Yamasaki D, Kusama Y, Ishikane M.
    Age-specific Distribution of Antimicrobial days of therapy (DOT) using National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB Japan) - Comparison with defined daily doses per 1000 inhabitants per day (DID).
    IDWEEK 2019, Washington D.C., US, October 2019.
13. Ishikane M, Tanaka C, Kusama Y, Tsuzuki S, Muraki Y, Yamasaki D, Tanabe M, Ohmagari N.
    Comparison of Patterns of National Oral Antibiotic Use between All Dentists and Medical Doctors in Japan in 2016 using the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
    IDWEEK 2019, Washington D.C., US, October 2019.
14. Moriyama Y, Ishikane M, Kusama Y, Matsunaga N, Tajima T, Hayakawa K, Ohmagari N.
    First National Survey of Antimicrobial and Antifungal Stewardship in Japan.
    IDWEEK 2019, Washington D.C., US, October 2019.
15. Ishikane M.
    Controlling MDROs Through Stewardship in Asia: Initiatives in Japan.
    IDWEEK 2019, Washington D.C., US, October 2019.
16. Matsunaga N.
    The incidence and antimicrobial prescription patterns of upper urinary tract infection in Japan.
    ECCMID2019, Amsterdam, Netherlands, April 2019.
17. Morioka S.
    Antibiotic Therapy for Hospital Acquired Pneumonia.
    APHC2019, Surabaya, Indonesia, August 2019.
18. Morioka S.
    Sepsis in patients with weeks of life expectancy.
    APHC2019, Surabaya Indonesia, August 2019.
19. Fujitomo Y, Yamamoto S, Gu Y, Takahashi R, Ohmagari N.
    Clinician-targeted refresher courses for the management of RTIs are effective in improving physicians’ skills for the management of acute RTIs and for promoting appropriate use of antibiotics in outpatient care.
    ICPIC 2019, Geneva, Switzerland, September 2019.

口頭・ポスター発表－国内学会・研究会

1. 忽那賢志.
   日本の輸入感染症の現状.
   第23回 日本渡航医学会学術集会, 東京, 7月,　2019年.
2. 忽那賢志 (Kutsuna S).
   Measures against infectious diseases in the Olympic and Paralympics About mosquito-borne infection and measles, rubella.
   第93回日本感染症学会総会・学術講演会,　名古屋,　4月, 2019年.
3. 忽那賢志 (Kutsuna S).
   Foreigner inflow from overseas and infection control（including measures against refugees).
   第94回日本感染症学会総会・学術講演会,　名古屋,　5月, 2020年.
4. 都築慎也.
   一般市民の抗菌薬と薬剤耐性に関する適切な知識の保持に関連する背景因子の検討.
   疫学会総会,　京都,　2月, 2020年.
5. 木下典子.
   小児における外来のキノロン系抗菌薬の本邦の処方状況を紹介し、位置づけについて解説する。.
   第654回　日本小児科学会東京都地方会講話会　指定発言, 東京, 5月,　2019年.
6. 木下 典子,　忽那 賢志,　安藤　秀二.
   Tick-borne lymphadenopathy (TIBOLA)の女児例.
   第51回日本小児感染症学会,　旭川,　10月,　2019年.
7. 川端　寛樹,　大曲 貴夫.
   次のAMRアクションプランにむけて 抗菌薬適正使用の指標と目標の設定をどうすべきか　～国際的な動向～ AMUとAMS.
   第35回日本環境感染学会,　横浜,　2月, 2020年.
8. 山元　佳.
   渡航前相談における麻疹・風疹・ムンプス・水痘抗体検査とキャッチアップ接種.
   第68回日本感染症学会東日本地方会学術集会,　仙台,　2019年.
9. 山元　佳.
   渡航前相談レジストリ Japan Pretravel Consultation Registryの設立と1年間の登録データについての考察.
   第23回日本渡航医学会学術集会.　東京, 7月,　2019年.
10. 山元　佳.
    呼吸器感染症に対するマルチプレックスPCRアッセイ（FilmArray®呼吸器パネル）の臨床応用.
    第31回臨床微生物迅速診断研究会 遺伝子検査機器セミナー,　前橋,　6月 ,　2019年.
11. 山元　佳.
    薬剤耐性（AMR）対策に最新検査をどう活かすか～感染症専門医がみる2020年に向けたトピックス～.
    第66回　日本臨床検査医学会学術集会,  岡山,　11月,　2019年.
12. 具芳明.
    薬剤耐性（AMR）対策アクションプランはどこまで進んだのか.
    第93回日本感染症学会総会・学術講演会,　名古屋,　4月, 2019年.
13. 具芳明.
    Current global situation of sepsis.
    第93回日本感染症学会総会・学術講演会,　名古屋,　4月,　2019年.
14. 藤友結実子、具芳明、大曲貴夫.
    医師会員を対象とした、抗菌薬適正使用の推進に関するアンケート調査.
    第93回日本感染症学会総会・学術講演会,　名古屋,　4月, 2019年.
15. 具芳明.
    多剤耐性菌の治療.
    第30回日本医学会総会2019中部,　名古屋,　4月 ,　2019年.
16. 具芳明.
    市民と医療従事者の意識は変わるのか.
    第67回日本化学療法学会総会,　東京,　5月,2019年.
17. 具芳明、藤友結実子、大曲貴夫.
    AMR臨床リファレンスセンターの教育啓発用資材の送付状況.
    第68回日本感染症学会東日本地方会学術集会・第67回日本化学療法学会東日本支部総会　合同学会,　仙台,　10月,　2019年.
18. 具芳明.
    教育啓発の進捗と今後.
    第35回日本環境感染学会総会・学術集会,　横浜, 2月,　2020年.
19. 野本英俊.
    多施設ネットワーク構築による本邦の海外渡航者の感染症レジストリ構築のための研究（J-RIDA）を用いた、海外渡航者の動物咬傷の評価.
    第23回日本渡航医学会学術集会,　東京, 7月,　2019年.
20. 井手　聡.
    海外入院歴のある渡航者のmedical evacuationで耐性菌により治療に難渋した2例.
    第68階日本感染症学会東日本地方会学術集会,　仙台,　10月,　2019年.
21. 日馬由貴、木村有希、石金正裕, 鈴木久美子、 松永展明、早川佳代子、大曲貴夫.
    レセプト情報を利用した高齢者施設の抗菌薬使用量調査における実行可能性と限界.
    第93回日本感染症学会総会・学術講演会,　名古屋,　4月, 2019年.
22. 太田雅之、石金正裕、目崎和久、大曲貴夫.
    当院における無症候性細菌尿の有病率と抗菌薬適正使用の後方視的コホート研究.
    第93回日本感染症学会総会・学術講演会,　名古屋,　4月, 2019年.
23. 石金正裕.
    海外からの薬剤耐性菌持ち込みの備え方.
    第23回日本渡航医学会, 東京,　7月,　2019年.
24. 守山祐樹、石金正裕、目崎和久、大曲貴夫.
    ペニシリン感受性黄色ブドウ球菌（PSSA）菌血症の標的治療としてペニシリンGとアンピシリンの有効性を評価する後向きコホート研究.
    第68回日本感染症学会東日本地方会学術集会,　仙台,　10月,　2019年.
25. 石金正裕、錦信吾、大西真.
    男性の淋菌における臨床的微生物学的前向きコホート研究.
    第68回日本感染症学会東日本地方会学術集会,　仙台,　10月,　2019年.
26. 石金正裕.
    薬剤耐性菌アウトブレイクに学ぶ耐性菌対応.
    第73回国立病院総合医学会,　名古屋,　11月,　2019年.
27. 石金正裕、鈴木久美子、 郁傑夫、木下典子、木村映善、大曲貴夫.
    スウェーデンのプライマリ・ケアにおける抗菌薬適正使用に有用な医療ITシステムの実態.
    39回医療情報学連合学会,　千葉市,　11月,　2019年.
28. 中本貴人, 忽那賢志, 中村啓二, 野本英俊, 安藤尚克, 塩尻大輔, 石金正裕, 大曲貴.
    異なる臨床像を呈したレプトスピラ症夫婦例.
    第93回日本感染症学会総会・学術講演会,　名古屋,　4月, 2019年.
29. 石金正裕.
    感染症の国際化に対する対応　「東京オリンピックなどのマスギャザリングと大会医学.
    「病態と薬理を理解して薬学的ケアを実践する」シリーズ　-　国際感染症Ⅱ,大阪市, 9月,　2019年.
30. 石金正裕.
    感染症の国際化に対する対応　「東京オリンピックなどのマスギャザリングと大会医学.
    「病態と薬理を理解して薬学的ケアを実践する」シリーズ　-　国際感染症Ⅱ,東京, 9月,　2019年.
31. 石金正裕.
    対策の実施と評価、再発防止の検討と提言.
    JICA九州　重症感染症などのアウトブレイク対応強化のための実地疫学研修 （管理者向け）, 東京,　12月,　2019年.
32. 石金正裕.
    重症インフルエンザ対策における医療対応　診断・治療・予防.
    JICA中国国別研修,　東京,　12月,　2019年.
33. 李祥任, 今井貴子,明石雅子,堀 成美.
    韓国の外国人医療実態調査～医療目的渡航者の受入体制整備の観点から.
    第23回日本渡航医学会学術集会, 東京, 7月, 2019年.
34. 李祥任,塩沢綾子,堀成美,高崎仁.
    外国生まれ結核患者の入国前スクリーニングの動向 -オーストラリアと日本の比較-.
    第4回国際臨床医学会, 福岡, 12月, 2019年.
35. 明石雅子, 堀成美, 李祥任, 杉浦康夫, 高崎仁.
    外国生まれ結核患者の帰国支援ー通訳の役割の観点からー.
    第4回国際臨床医学会, 福岡, 12月, 2019年.
36. Sugai KM, Nomura S, Sakamoto H, Maruyama-Sakurai K, Nakmura H, Muto Y, Lee S, Kubota A, Ishizuka A, Sumi M, Kawaguchi M, Akashi H, Hinoshita E, Inoue H, Shibuya K.
    Japan’s development assistance for health: a temporal, geographical, and focus-specific evaluation of bilateral and multilateral financial contributions, launching the Japan Tracker.
    第34回日本国際保健医療学会, 三重, 12月, 2019年.

著書・総説

単行本－欧文

1. Matsunaga N, Gu Y, Ohmagari N.
   The One Health approach and public education and awareness-raising activities in Japan.
   AMR CONTROL 2019-20 The World Alliance Against Antibiotic Resistance (WAAAR) (online publication). p32-37, 2019.

単行本－和文

1. 具芳明.
   外来で診る感染症　感染症診療コツのコツ. 具芳明 (編集).
   日本医事新報社東京, 2020年.
2. 野本英俊.
   風疹ウイルス抗体検査.
   臨床雑誌内科. 南江堂, p912-913, 2019年.
3. 野本英俊.
   ムンプスウイルス抗体検査.
   臨床雑誌内科. 南江堂, p914, 2019年
4. 野本英俊.
   麻疹ウイルス抗体検査法.
   臨床雑誌内科. 南江堂, p915, 2019年.
5. 石金 正裕 (著), うえたに夫婦 (著).
   まだ変えられる! くすりがきかない未来: 知っておきたい薬剤耐性(AMR)のはなし.
   南山堂, 2019年.
6. 石金正裕.
   「野兎病」、「ペスト」.
   内科学. 南学 正臣 (編集), 伊藤 裕 (編集), 大田 健 (編集), 小澤 敬也 (編集), 下村 伊一郎 (編集), 田中 章景 (編集), 千葉 勉 (編集)          中山書店, 2019年.

総説

1. 日馬 由貴.
   日本の高齢者施設におけるレセプト情報を利用した抗菌薬使用量調査の問題点.
   日本化学療法学会雑誌 (1340-7007), 68巻2号, 210-215, 3月, 2020年.
2. 大曲貴夫 (Ohmagari N).
   National Action Plan on Antimicrobial Resistance (AMR) 2016-2020 and relevant activities in Japan (和訳中) (英語).
   Global Health & Medicine(2434-9186), 1巻2号, 71-77, 12月, 2019年.
3. 早川 佳代子.
   本邦におけるAntimicrobial Resistance (薬剤耐性) 対策サーベイランスの今後.
   日本環境感染学会誌 (1882-532X), 4巻4号, 215-221, 7月, 2019年.
4. 具 芳明.
   海外における薬剤耐性と抗菌薬使用の現状.
   日本化学療法学会雑誌 (1340-7007), 67巻1号, 13-22, 1月, 2019年.
5. 秋山　裕太郎.
   精神科病院に関わる身体合併症とその対策】精神科病棟における感染対策と抗菌薬の適正使用 (解説/特集).
   日本精神科病院協会雑誌 (1347-4103), 38巻8号, 734-737, 8月, 2019年.

その他